This article was originally published in Start Up
Executive SummaryPap smears for women are a necessary evil. Early screening is a key reason the number of cervical cancer deaths in developed countries is so much lower than elsewhere in the world. Now, Diamics hopes to offer a molecular diagnostic for cervical cancer at the point-of-care.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.